Opportunity
Simpler Grants.gov #RFA-NS-26-012
NIH Funding Opportunity: Stroke Preclinical Assessment Network (SPAN) Coordinating Center and Testing Sites
Buyer
National Institutes of Health
Posted
September 02, 2025
Respond By
March 18, 2026
Identifier
RFA-NS-26-012
NAICS
541715
The National Institutes of Health (NIH), through the National Institute of Neurological Disorders and Stroke, is preparing a funding opportunity to establish the Stroke Preclinical Assessment Network (SPAN): - NIH seeks to fund a collaborative research network for translational studies in acute ischemic stroke - Up to six peer-reviewed data collection sites and one Coordinating Center will be supported - The Coordinating Center will handle administration, coordination, and data sharing across the network - No specific Original Equipment Manufacturers (OEMs) or vendors are named, as this is a research grant - Expected funding amount is $500,000, with one anticipated award - Eligible applicants include government agencies, educational institutions, nonprofits, businesses, and foreign organizations - Unique requirements: - Demonstrated expertise in multi-center translational studies for acute cerebroprotection - Ability to participate in a collaborative research network
Description
The National Institute of Neurological Disorders and Stroke intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the Coordinating Center and Testing Sites of the Stroke Preclinical Assessment Network (SPAN), a preclinical network to support translational studies for cerebroprotection in experimental models of acute ischemic stroke. This NOFO will utilize Cooperative Agreements (U01) and aims to establish a collaborative network comprising up to 6 peer-reviewed data collection sites and a Coordinating Center to oversee administration, coordination, and data sharing. Applications are not being solicited at this time; the notice is provided to allow potential applicants time to develop collaborations and responsive projects. Investigators with expertise in multi-center translational studies for acute cerebroprotection are encouraged to consider applying.